ReviewAntibiotic resistance among clinically important Gram-positive bacteria in the UK
References (77)
- et al.
A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales
J Hosp Infect
(1990) - et al.
Characterisation of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods
J Hosp Infect
(1993) - et al.
A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phagetype (EMRSA-16)
J Hosp Infect
(1995) - et al.
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
Lancet
(1997) - et al.
Surveillance of methicillin-resistant Staphylococcus aureus in England and Wales 1989–1990
J Hosp Infect
(1991) - et al.
Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95
Lancet
(1997) - et al.
Continuing increase in invasive methicillin-resistant infection
Lancet
(1997) Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA)
J Hosp Infect
(1997)- et al.
Ciprofloxacin-resistant Staphylococcus epidermidis and hands
Lancet
(1997) - et al.
A resistant pneumococcus
Lancet
(1967)
Multiply-resistant pneumococcus
Lancet
(1978)
Ear infection due to penicillin-resistant pneumococcus in immunodeficient child
Lancet
(1979)
Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989-94
J Infect
(1996)
Penicillin-resistant pneumococci in a Merseyside hospital
J Hosp Infect
(1991)
The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci
Clin Microbiol Infect
(1997)
Vancomycin-resistant enterococci
Lancet
(1988)
Emergence of vancomycin-resistant enterococci in New York City
Lancet
(1993)
Oxazolidinones: New antibacterial agents
Trends Microbiol
(1997)
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci
Lancet
(1997)
Methicillin-resistant Staphylococcus aureus in England and Wales
CDR Rev
(1992)
Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications
Clin Microbiol Rev
(1997)
Epidemic methicillin resistant Staphylococcus aureus
CDR
(1997)
Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community
J Hosp Infect
(1995)
Prevalence of mupirocin resistance in Staphylococcus aureus
J Hosp Infect
(1995)
Current perspectives on glycopeptide resistance
Clin Microbiol Rev
(1995)
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
J Antiniicrob Chemother
(1997)
Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997
Morbid Mortal Weekly Rep
(1997)
Detecting vancomycin intermediate Staphylococcus aureus
CDR
(1997)
Gram-positive resistance: challenges for the development of new antibiotics
J Antimicrob Chemother
(1997)
Surveillance of Gram positive pathogens in the UK (1996)
Percentages and distributions of teicoplanin-and vancomycin-resistant strains among coagulase-negative staphylococci
Antimicrob Agents Chemother
(1990)
Susceptibility of pneumococci to nine antibiotics
Am J Med Sci
(1965)
Meningitis due to a relatively penicillin-resistant pneumococcus
Br Med J
(1976)
Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995
Br Med J
(1996)
Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992
CDR Rev
(1995)
Antimicrobial resistance of pneumococci isolated from blood and cerebrospinal fluid 1993 and 1994
CDR
(1995)
Pneumococcal bacteraemia and meningitis in England and Wales, 1993–1995
Comm Dis Publ Hlth
(1998)
Cited by (46)
Implementation and outcomes of hospital-wide computerized antimicrobial approval system and on-the-spot education in a traumatic intensive care unit in Taiwan
2018, Journal of Microbiology, Immunology and InfectionCitation Excerpt :In ICUs, inappropriate antibiotic usage was higher in patients undergoing surgery,5 while 5%–57% of patients develop nosocomial infections.7,11 Multidrug resistant (MDR) bacteria, both gram positive cocci and gram negative bacilli (GNB), are increasingly widespread processes in hospital settings.12,13 The hospital-wide computerized antimicrobial approval system (HCAAS) was developed in September 2004 at Chang-Gung Memorial Hospital (CGMH), and the implementation of an online antibiotic control program was first reported at CGMH-Taoyuan in Taiwan in 2011.14
Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)
2008, Enfermedades Infecciosas y Microbiologia ClinicaMinimising moxifloxacin resistance with tuberculosis
2008, The Lancet Infectious DiseasesRhys-davies exsanguinator: a haven for bacteria
2007, Journal of Hand Surgery: European VolumeEvaluation of the in vitro activity of daptomycin against 19 615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)
2007, Diagnostic Microbiology and Infectious DiseaseActivity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid
2004, International Journal of Antimicrobial Agents
Copyright © 1998 Published by Elsevier Ltd.